Ashwin Gupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ashwin Gupta has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
- Nathan Houchens
Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
15 shared publications Nathan Houchens
Medicine Service, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan, USA
5 shared publicationsDavid Ratz
Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan (D.R., A.B.G.)
4 shared publicationsVineet Chopra
Division of Hospital Medicine, Department of Medicine , University of Michigan Medical School , Ann Arbor , MI , USA
4 shared publicationsAnurag N. Malani
Section of Infectious Diseases, Trinity Health Michigan, Ann Arbor, Michigan (A.N.M.)
3 shared publicationsJennifer K. Horowitz
Division of Hospital Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan (J.K.H., S.A.F.)
3 shared publications
Latest Publications
- 1 May 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (5) , 629-636
Short Versus Longer Antibiotic Duration for Community-Acquired Pneumonia
Shorter antibiotic courses for community-acquired pneumonia (CAP) may reduce adverse effects and resistance. However, real-world data supporting very short durations remain limited. To evaluate the safety and effectiveness of 3- to 4-day versus 5-day or more antibiotic durations in hospitalized patients with CAP who achieve clinical stability by day 3 (afebrile, no new oxygen, and stable vital signs). Observational emulation of a target trial. 67 Michigan hospitals between 2017 and 2024. Adults hospitalized (non-intensive care unit) with CAP who received 3 days of antibiotics, were clinically stable by antibiotic day 3, and met the strict eligibility criteria of the Pneumonia Short Treatment trial. 0 to 1 additional days of antibiotic treatment versus 2 or more days of additional antibiotic treatment (that is, shorter [3 to 4 days] vs. longer [≥5 days] total antibiotic duration). The main outcome was 30-day all-cause mortality. Other outcomes included 30-day hospital readmission, urgent health care visits, and Clostridioides difficile infection. Among 55 517 hospitalized patients with CAP, 5620 (10.1%) ultimately met eligibility criteria for short-course therapy after comorbidity, clinical stability, and treatment duration criteria were applied. Median age of eligible patients was 68.2 years, and 54.3% were men. Median antibiotic duration was 7 days, with only 7.9% (444 of 5620) receiving 3 to 4 days. Thirty-day adjusted risk ratios for short- versus long-course antibiotic therapy were 0.89 for mortality (95% CI, 0.01 to 2.25), 1.07 for readmission (CI, 0.81 to 1.42), 0.94 for urgent visit (CI, 0.70 to 1.28), and 1.01 for C difficile infection (CI, 0.18 to 5.68). Few short-duration patients and potential residual confounding. Only 10.1% of inpatients with CAP met the strict eligibility criteria for short-course therapy. The short- and longer-course antibiotic treatment groups had similar mortality rates, and there was little difference in benefits and harms. Blue Cross Blue Shield of Michigan and Blue Care Network.
- 1 May 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (5) , 629-636
Short Versus Longer Antibiotic Duration for Community-Acquired Pneumonia
Shorter antibiotic courses for community-acquired pneumonia (CAP) may reduce adverse effects and resistance. However, real-world data supporting very short durations remain limited. To evaluate the safety and effectiveness of 3- to 4-day versus 5-day or more antibiotic durations in hospitalized patients with CAP who achieve clinical stability by day 3 (afebrile, no new oxygen, and stable vital signs). Observational emulation of a target trial. 67 Michigan hospitals between 2017 and 2024. Adults hospitalized (non-intensive care unit) with CAP who received 3 days of antibiotics, were clinically stable by antibiotic day 3, and met the strict eligibility criteria of the Pneumonia Short Treatment trial. 0 to 1 additional days of antibiotic treatment versus 2 or more days of additional antibiotic treatment (that is, shorter [3 to 4 days] vs. longer [≥5 days] total antibiotic duration). The main outcome was 30-day all-cause mortality. Other outcomes included 30-day hospital readmission, urgent health care visits, and Clostridioides difficile infection. Among 55 517 hospitalized patients with CAP, 5620 (10.1%) ultimately met eligibility criteria for short-course therapy after comorbidity, clinical stability, and treatment duration criteria were applied. Median age of eligible patients was 68.2 years, and 54.3% were men. Median antibiotic duration was 7 days, with only 7.9% (444 of 5620) receiving 3 to 4 days. Thirty-day adjusted risk ratios for short- versus long-course antibiotic therapy were 0.89 for mortality (95% CI, 0.01 to 2.25), 1.07 for readmission (CI, 0.81 to 1.42), 0.94 for urgent visit (CI, 0.70 to 1.28), and 1.01 for C difficile infection (CI, 0.18 to 5.68). Few short-duration patients and potential residual confounding. Only 10.1% of inpatients with CAP met the strict eligibility criteria for short-course therapy. The short- and longer-course antibiotic treatment groups had similar mortality rates, and there was little difference in benefits and harms. Blue Cross Blue Shield of Michigan and Blue Care Network.
- Top Cited PapersOpen Access
- 1 February 2026
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 186 (2) , 192
Antibiotic De-Escalation in Adults Hospitalized for Community-Onset Sepsis
Importance: Prolonged exposure to broad-spectrum antibiotics (BSA) may be associated with patient harm. Objective: To assess outcomes of BSA de-escalation compared with continuation on encounter day 4 in patients hospitalized for community-onset sepsis. Design, Setting, and Participants: This target trial emulation study was conducted at 67 hospitals participating in the Michigan Hospital Medicine Safety Consortium. Patients 18 years and older hospitalized for community-onset sepsis from June 2020 through September 2024 who initiated empiric BSA therapy without evidence of multidrug-resistant organism infection were included. Data were analyzed from September 2024 to November 2025. Exposure: Inverse probability of treatment–weighted cohort exposed to de-escalation of BSA vs continuation at day 4. Main Outcomes and Measures: The primary outcome was 90-day all-cause mortality. Secondary outcomes included in-hospital mortality, 30-day mortality, length of hospitalization, and days of antibiotic therapy. Results: Among 36 924 patients with community-onset sepsis, 18 559 (50.3%) were female, 18 365 (49.7%) were male, and the median (IQR) age was 71 (61-80) years. A total of 6926 (18.8%) and 11 149 (30.2%) were eligible for target trial emulations evaluating de-escalation of anti–methicillin-resistant Staphylococcus aureus (MRSA) and anti– Pseudomonas aeruginosa (PSA; or other resistant gram-negative bacteria) antibiotics, respectively. Of these, 2993 (43.2%) and 2493 (22.4%) were de-escalated from anti-MRSA and anti-PSA coverage. After weighting, patients who were de-escalated vs continued on BSA were well balanced on baseline characteristics. In weighted analyses, anti-MRSA and anti-PSA de-escalation were associated with similar 90-day mortality as continued BSA therapy (anti-MRSA: odds ratio, 1.00; 95% CI, 0.88-1.14; anti-PSA: odds ratio, 0.98; 95% CI, 0.86-1.13). Additionally, anti-MRSA and anti-PSA de-escalation were associated with fewer days of antibiotics to day 14 (anti-MRSA de-escalation: risk ratio [RR], 0.91; 95% CI, 0.89-0.93; anti-PSA de-escalation: RR, 0.91; 95% CI, 0.88-0.93) and shorter length of hospitalization (anti-MRSA de-escalation: RR, 0.88; 95% CI, 0.85-0.92; anti-PSA de-escalation: RR, 0.91; 0.88-0.93). All other secondary outcomes were similar. Across 67 hospitals, the proportion of eligible patients de-escalated from BSA varied more than 2-fold (anti-MRSA de-escalation, 27.3% to 61.7%; anti-PSA de-escalation, 6.9% to 37.7%). Conclusions and Relevance: In this study, de-escalation of empiric BSA therapy at day 4 was associated with similar safety outcomes, fewer antibiotic days, and shorter length of hospitalization among patients with community-onset sepsis compared with those who continued BSA therapy but varied widely in practice.
- 1 February 2026
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 186 (2) , 192
Top Cited PapersOpen AccessAntibiotic De-Escalation in Adults Hospitalized for Community-Onset Sepsis
Importance: Prolonged exposure to broad-spectrum antibiotics (BSA) may be associated with patient harm. Objective: To assess outcomes of BSA de-escalation compared with continuation on encounter day 4 in patients hospitalized for community-onset sepsis. Design, Setting, and Participants: This target trial emulation study was conducted at 67 hospitals participating in the Michigan Hospital Medicine Safety Consortium. Patients 18 years and older hospitalized for community-onset sepsis from June 2020 through September 2024 who initiated empiric BSA therapy without evidence of multidrug-resistant organism infection were included. Data were analyzed from September 2024 to November 2025. Exposure: Inverse probability of treatment–weighted cohort exposed to de-escalation of BSA vs continuation at day 4. Main Outcomes and Measures: The primary outcome was 90-day all-cause mortality. Secondary outcomes included in-hospital mortality, 30-day mortality, length of hospitalization, and days of antibiotic therapy. Results: Among 36 924 patients with community-onset sepsis, 18 559 (50.3%) were female, 18 365 (49.7%) were male, and the median (IQR) age was 71 (61-80) years. A total of 6926 (18.8%) and 11 149 (30.2%) were eligible for target trial emulations evaluating de-escalation of anti–methicillin-resistant Staphylococcus aureus (MRSA) and anti– Pseudomonas aeruginosa (PSA; or other resistant gram-negative bacteria) antibiotics, respectively. Of these, 2993 (43.2%) and 2493 (22.4%) were de-escalated from anti-MRSA and anti-PSA coverage. After weighting, patients who were de-escalated vs continued on BSA were well balanced on baseline characteristics. In weighted analyses, anti-MRSA and anti-PSA de-escalation were associated with similar 90-day mortality as continued BSA therapy (anti-MRSA: odds ratio, 1.00; 95% CI, 0.88-1.14; anti-PSA: odds ratio, 0.98; 95% CI, 0.86-1.13). Additionally, anti-MRSA and anti-PSA de-escalation were associated with fewer days of antibiotics to day 14 (anti-MRSA de-escalation: risk ratio [RR], 0.91; 95% CI, 0.89-0.93; anti-PSA de-escalation: RR, 0.91; 95% CI, 0.88-0.93) and shorter length of hospitalization (anti-MRSA de-escalation: RR, 0.88; 95% CI, 0.85-0.92; anti-PSA de-escalation: RR, 0.91; 0.88-0.93). All other secondary outcomes were similar. Across 67 hospitals, the proportion of eligible patients de-escalated from BSA varied more than 2-fold (anti-MRSA de-escalation, 27.3% to 61.7%; anti-PSA de-escalation, 6.9% to 37.7%). Conclusions and Relevance: In this study, de-escalation of empiric BSA therapy at day 4 was associated with similar safety outcomes, fewer antibiotic days, and shorter length of hospitalization among patients with community-onset sepsis compared with those who continued BSA therapy but varied widely in practice.
- Open Access
- 29 August 2025
- Published by University of Michigan Library in Michigan Journal of Medicine
- Vol. 8
Ethical Considerations of Withdrawal of Care Due to Altered Mental Status in the Setting of Treatable Organic Cause: A Case Report
Background: Altered mental status (AMS) in elderly patients is a common but nonspecific presentation, frequently associated with failure to thrive (FTT). AMS may stem from organic causes, such as infection, or from nonorganic factors, including psychosocial stressors. When patients with AMS present conflicting code status preferences compared to surrogate decision-makers, clinicians must balance patient autonomy with nonmaleficence when assessing decision-making capacity. Case and Course: A 77-year-old man presented with generalized weakness and poor oral intake. His wife reported that the patient would elect a do not resuscitate/do not intubate status as he wishes to die peacefully, while the patient stated a desire for full code status. On arrival, he was somnolent, oriented only to person and place. Workup incidentally revealed a small bowel obstruction (SBO). With the patient’s and family’s consent, nonsurgical management was initiated using nasogastric decompression and intravenous hydration. Within four days, bowel function and oral intake normalized, and the patient regained full orientation and memory. Upon recovery, he reaffirmed his preference for full code status. Discussion: This case illustrates the importance of identifying reversible causes of AMS even when the family states the patient’s desire to die. Acute illnesses such as SBO can transiently impair capacity, and surrogate reports of prior wishes may not reflect the patient’s true preferences. Clinicians should avoid assuming chronic incapacity based solely on baseline cognitive decline and should instead perform a targeted diagnostic workup to exclude acute causes of cognitive decline. Emotional factors, such as a perceived burden on family, may also influence expressed wishes. We recommend integrating the patient’s expressed wishes and underlying emotional state into capacity assessment, and, if capacity is lacking, deferring to family preferences while ensuring they align with the patient’s known values.
- 29 August 2025
- Published by University of Michigan Library in Michigan Journal of Medicine
- Vol. 8
Open AccessEthical Considerations of Withdrawal of Care Due to Altered Mental Status in the Setting of Treatable Organic Cause: A Case Report
Background: Altered mental status (AMS) in elderly patients is a common but nonspecific presentation, frequently associated with failure to thrive (FTT). AMS may stem from organic causes, such as infection, or from nonorganic factors, including psychosocial stressors. When patients with AMS present conflicting code status preferences compared to surrogate decision-makers, clinicians must balance patient autonomy with nonmaleficence when assessing decision-making capacity. Case and Course: A 77-year-old man presented with generalized weakness and poor oral intake. His wife reported that the patient would elect a do not resuscitate/do not intubate status as he wishes to die peacefully, while the patient stated a desire for full code status. On arrival, he was somnolent, oriented only to person and place. Workup incidentally revealed a small bowel obstruction (SBO). With the patient’s and family’s consent, nonsurgical management was initiated using nasogastric decompression and intravenous hydration. Within four days, bowel function and oral intake normalized, and the patient regained full orientation and memory. Upon recovery, he reaffirmed his preference for full code status. Discussion: This case illustrates the importance of identifying reversible causes of AMS even when the family states the patient’s desire to die. Acute illnesses such as SBO can transiently impair capacity, and surrogate reports of prior wishes may not reflect the patient’s true preferences. Clinicians should avoid assuming chronic incapacity based solely on baseline cognitive decline and should instead perform a targeted diagnostic workup to exclude acute causes of cognitive decline. Emotional factors, such as a perceived burden on family, may also influence expressed wishes. We recommend integrating the patient’s expressed wishes and underlying emotional state into capacity assessment, and, if capacity is lacking, deferring to family preferences while ensuring they align with the patient’s known values.
- Open Access
- 1 January 2025
- Published by BMJ in BMJ Open Quality
- Vol. 14 (1) , e003093
Resident encounters with disruptive workplace behaviours in Japan: findings from a national cross-sectional study
Importance: Disruptive workplace behaviours (DWBs) between healthcare professionals compromise patient care quality and organisational culture, impacting staff morale, communication and teamwork. Residents are particularly vulnerable to it from nurses and supervisors. Objective: Elucidate factors associated with DWBs experienced by residents. Design: Nationwide cross-sectional study using a web-based survey. Setting: Japanese postgraduate clinical training hospitals. Participants: First- and second-year postgraduate residents were surveyed between 15 and 31 January 2023, immediately after participating in the nationally administered computer-based residency exam. Exposure: None. Main outcomes and measures: Primary outcomes include previously published eight types of DWBs experienced by residents. Resident characteristics at the time of the study were used. Hospital data (location of the training hospital, number of beds, number of emergency transports, average length of hospital stays, number of outpatients per day and the actual number of residents, full-time physicians and nurses) were obtained from Japan’s largest hospital information database. Results: Of 5403 residents analysed, 68.3% were males, and 84.9% were under 28 years of age. Residents reported encountering DWBs from physicians and nurses approximately 35% of the time, a roughly equivalent percentage from both groups. After multivariate logistic regression analysis, the likelihood of encountering DWBs from nurses increased with hospital size (>700 beds; adjusted OR (aOR) 2.19; 501–700 beds; aOR 1.45 and 301–500 beds; aOR 1.26, all statistically significant). Furthermore, DWBs from nurses were significantly more prevalent in settings with higher admissions per nurse (aOR 1.70). DWBs from physicians were significantly more prevalent towards male (vs female) residents (aOR 1.60) and less likely among the second-year postgraduate (vs first-year postgraduate) residents (aOR 0.87). Conclusions: DWBs from nurses are significantly more common with increasing hospital bed numbers and increase with the number of admissions per nurse. No such correlation was observed with DWBs from physicians. Male residents experience more DWBs than female residents.
- 1 January 2025
- Published by BMJ in BMJ Open Quality
- Vol. 14 (1) , e003093
Open AccessResident encounters with disruptive workplace behaviours in Japan: findings from a national cross-sectional study
Importance: Disruptive workplace behaviours (DWBs) between healthcare professionals compromise patient care quality and organisational culture, impacting staff morale, communication and teamwork. Residents are particularly vulnerable to it from nurses and supervisors. Objective: Elucidate factors associated with DWBs experienced by residents. Design: Nationwide cross-sectional study using a web-based survey. Setting: Japanese postgraduate clinical training hospitals. Participants: First- and second-year postgraduate residents were surveyed between 15 and 31 January 2023, immediately after participating in the nationally administered computer-based residency exam. Exposure: None. Main outcomes and measures: Primary outcomes include previously published eight types of DWBs experienced by residents. Resident characteristics at the time of the study were used. Hospital data (location of the training hospital, number of beds, number of emergency transports, average length of hospital stays, number of outpatients per day and the actual number of residents, full-time physicians and nurses) were obtained from Japan’s largest hospital information database. Results: Of 5403 residents analysed, 68.3% were males, and 84.9% were under 28 years of age. Residents reported encountering DWBs from physicians and nurses approximately 35% of the time, a roughly equivalent percentage from both groups. After multivariate logistic regression analysis, the likelihood of encountering DWBs from nurses increased with hospital size (>700 beds; adjusted OR (aOR) 2.19; 501–700 beds; aOR 1.45 and 301–500 beds; aOR 1.26, all statistically significant). Furthermore, DWBs from nurses were significantly more prevalent in settings with higher admissions per nurse (aOR 1.70). DWBs from physicians were significantly more prevalent towards male (vs female) residents (aOR 1.60) and less likely among the second-year postgraduate (vs first-year postgraduate) residents (aOR 0.87). Conclusions: DWBs from nurses are significantly more common with increasing hospital bed numbers and increase with the number of admissions per nurse. No such correlation was observed with DWBs from physicians. Male residents experience more DWBs than female residents.
- 12 June 2024
- Published by BMJ in BMJ Quality & Safety
- Vol. 33 (8) , 544-548
Quality and safety in the literature: August 2024
- 12 June 2024
- Published by BMJ in BMJ Quality & Safety
- Vol. 33 (8) , 544-548
Quality and safety in the literature: August 2024
- 1 June 2024
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 117 (6) , 345-346
The “Three-Question Approach” to Medical Assessments and Plans: A Standardized Approach for Medical Trainees
Transitioning from preclinical to clinical education can be a terrifying prospect for medical students and is commonly cited as a major point of anxiety in medical education. Anxiety around clerkship performance is likely to become worse in the coming years. Because the US Medical Licensing Examination Step 1 has been ungraded and medical schools increasingly enact pass/fail preclinical...
- 1 June 2024
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 117 (6) , 345-346
The “Three-Question Approach” to Medical Assessments and Plans: A Standardized Approach for Medical Trainees
Transitioning from preclinical to clinical education can be a terrifying prospect for medical students and is commonly cited as a major point of anxiety in medical education. Anxiety around clerkship performance is likely to become worse in the coming years. Because the US Medical Licensing Examination Step 1 has been ungraded and medical schools increasingly enact pass/fail preclinical...
- Open Access
- 10 May 2024
- Published by Walter de Gruyter GmbH in Diagnosis
- Vol. 12 (1) , 68-73
Implementation of a bundle to improve diagnosis in hospitalized patients: lessons learned
Objectives: The inpatient setting is a challenging clinical environment where systems and situational factors predispose clinicians to making diagnostic errors. Environmental complexities limit trialing of interventions to improve diagnostic error in active inpatient clinical settings. Informed by prior work, we piloted a multi-component intervention designed to reduce diagnostic error to understand its feasibility and uptake. Methods: From September 2018 to June 2019, we conducted a prospective, pre-test/post-test pilot study of hospital medicine physicians during admitting shifts at a tertiary-care, academic medical center. Optional intervention components included use of dedicated workspaces, privacy barriers, noise cancelling headphones, application-based breathing exercises, a differential diagnosis expander application, and a checklist to enable a diagnostic pause. Participants rated their confidence in patient diagnoses and completed a survey on intervention component use. Data on provider resource utilization and patient diagnoses were collected, and qualitative interviews were held with a subset of participants in order to better understand experience with the intervention. Results: Data from 37 physicians and 160 patients were included. No intervention component was utilized by more than 50 % of providers, and no differences were noted in diagnostic confidence or number of diagnoses documented pre- vs. post-intervention. Lab utilization increased, but there were no other differences in resource utilization during the intervention. Qualitative feedback highlighted workflow integration challenges, among others, for poor intervention uptake. Conclusions: Our pilot study demonstrated poor feasibility and uptake of an intervention designed to reduce diagnostic error. This study highlights the unique challenges of implementing solutions within busy clinical environments.
- 10 May 2024
- Published by Walter de Gruyter GmbH in Diagnosis
- Vol. 12 (1) , 68-73
Open AccessImplementation of a bundle to improve diagnosis in hospitalized patients: lessons learned
Objectives: The inpatient setting is a challenging clinical environment where systems and situational factors predispose clinicians to making diagnostic errors. Environmental complexities limit trialing of interventions to improve diagnostic error in active inpatient clinical settings. Informed by prior work, we piloted a multi-component intervention designed to reduce diagnostic error to understand its feasibility and uptake. Methods: From September 2018 to June 2019, we conducted a prospective, pre-test/post-test pilot study of hospital medicine physicians during admitting shifts at a tertiary-care, academic medical center. Optional intervention components included use of dedicated workspaces, privacy barriers, noise cancelling headphones, application-based breathing exercises, a differential diagnosis expander application, and a checklist to enable a diagnostic pause. Participants rated their confidence in patient diagnoses and completed a survey on intervention component use. Data on provider resource utilization and patient diagnoses were collected, and qualitative interviews were held with a subset of participants in order to better understand experience with the intervention. Results: Data from 37 physicians and 160 patients were included. No intervention component was utilized by more than 50 % of providers, and no differences were noted in diagnostic confidence or number of diagnoses documented pre- vs. post-intervention. Lab utilization increased, but there were no other differences in resource utilization during the intervention. Qualitative feedback highlighted workflow integration challenges, among others, for poor intervention uptake. Conclusions: Our pilot study demonstrated poor feasibility and uptake of an intervention designed to reduce diagnostic error. This study highlights the unique challenges of implementing solutions within busy clinical environments.
- Open Access
- 1 May 2024
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 184 (5) , 548-556
Inappropriate Diagnosis of Pneumonia Among Hospitalized Adults
Importance: Little is known about incidence of, risk factors for, and harms associated with inappropriate diagnosis of community-acquired pneumonia (CAP).Objective: To characterize inappropriate diagnosis of CAP in hospitalized patients.Design, Setting, and Participants: This prospective cohort study, including medical record review and patient telephone calls, took place across 48 Michigan hospitals. Trained abstractors retrospectively assessed hospitalized patients treated for CAP between July 1, 2017, and March 31, 2020. Patients were eligible for inclusion if they were adults admitted to general care with a discharge diagnostic code of pneumonia who received antibiotics on day 1 or 2 of hospitalization. Data were analyzed from February to December 2023.Main Outcomes and Measures: Inappropriate diagnosis of CAP was defined using a National Quality Forum–endorsed metric as CAP-directed antibiotic therapy in patients with fewer than 2 signs or symptoms of CAP or negative chest imaging. Risk factors for inappropriate diagnosis were assessed and, for those inappropriately diagnosed, 30-day composite outcomes (mortality, readmission, emergency department visit, Clostridioides difficile infection, and antibiotic-associated adverse events) were documented and stratified by full course (>3 days) vs brief (≤3 days) antibiotic treatment using generalized estimating equation models adjusting for confounders and propensity for treatment.Results: Of the 17 290 hospitalized patients treated for CAP, 2079 (12.0%) met criteria for inappropriate diagnosis (median [IQR] age, 71.8 [60.1-82.8] years; 1045 [50.3%] female), of whom 1821 (87.6%) received full antibiotic courses. Compared with patients with CAP, patients inappropriately diagnosed were older (adjusted odds ratio [AOR], 1.08; 95% CI, 1.05-1.11 per decade) and more likely to have dementia (AOR, 1.79; 95% CI, 1.55-2.08) or altered mental status on presentation (AOR, 1.75; 95% CI, 1.39-2.19). Among those inappropriately diagnosed, 30-day composite outcomes for full vs brief treatment did not differ (25.8% vs 25.6%; AOR, 0.98; 95% CI, 0.79-1.23). Full vs brief duration of antibiotic treatment among patients was associated with antibiotic-associated adverse events (31 of 1821 [2.1%] vs 1 of 258 [0.4%]; P = .03).Conclusions and Relevance: In this cohort study, inappropriate diagnosis of CAP among hospitalized adults was common, particularly among older adults, those with dementia, and those presenting with altered mental status. Full-course antibiotic treatment of those inappropriately diagnosed with CAP may be harmful.
- 1 May 2024
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 184 (5) , 548-556
Open AccessInappropriate Diagnosis of Pneumonia Among Hospitalized Adults
Importance: Little is known about incidence of, risk factors for, and harms associated with inappropriate diagnosis of community-acquired pneumonia (CAP).Objective: To characterize inappropriate diagnosis of CAP in hospitalized patients.Design, Setting, and Participants: This prospective cohort study, including medical record review and patient telephone calls, took place across 48 Michigan hospitals. Trained abstractors retrospectively assessed hospitalized patients treated for CAP between July 1, 2017, and March 31, 2020. Patients were eligible for inclusion if they were adults admitted to general care with a discharge diagnostic code of pneumonia who received antibiotics on day 1 or 2 of hospitalization. Data were analyzed from February to December 2023.Main Outcomes and Measures: Inappropriate diagnosis of CAP was defined using a National Quality Forum–endorsed metric as CAP-directed antibiotic therapy in patients with fewer than 2 signs or symptoms of CAP or negative chest imaging. Risk factors for inappropriate diagnosis were assessed and, for those inappropriately diagnosed, 30-day composite outcomes (mortality, readmission, emergency department visit, Clostridioides difficile infection, and antibiotic-associated adverse events) were documented and stratified by full course (>3 days) vs brief (≤3 days) antibiotic treatment using generalized estimating equation models adjusting for confounders and propensity for treatment.Results: Of the 17 290 hospitalized patients treated for CAP, 2079 (12.0%) met criteria for inappropriate diagnosis (median [IQR] age, 71.8 [60.1-82.8] years; 1045 [50.3%] female), of whom 1821 (87.6%) received full antibiotic courses. Compared with patients with CAP, patients inappropriately diagnosed were older (adjusted odds ratio [AOR], 1.08; 95% CI, 1.05-1.11 per decade) and more likely to have dementia (AOR, 1.79; 95% CI, 1.55-2.08) or altered mental status on presentation (AOR, 1.75; 95% CI, 1.39-2.19). Among those inappropriately diagnosed, 30-day composite outcomes for full vs brief treatment did not differ (25.8% vs 25.6%; AOR, 0.98; 95% CI, 0.79-1.23). Full vs brief duration of antibiotic treatment among patients was associated with antibiotic-associated adverse events (31 of 1821 [2.1%] vs 1 of 258 [0.4%]; P = .03).Conclusions and Relevance: In this cohort study, inappropriate diagnosis of CAP among hospitalized adults was common, particularly among older adults, those with dementia, and those presenting with altered mental status. Full-course antibiotic treatment of those inappropriately diagnosed with CAP may be harmful.
- Open Access
- 31 January 2024
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 78 (6) , 1403-1411
Development of Patient Safety Measures to Identify Inappropriate Diagnosis of Common Infections
Inappropriate diagnosis of infections results in antibiotic overuse and may delay diagnosis of underlying conditions. Here we describe the development and characteristics of 2 safety measures of inappropriate diagnosis of urinary tract infection (UTI) and community-acquired pneumonia (CAP), the most common inpatient infections on general medicine services. Measures were developed from guidelines and literature and adapted based on data from patients hospitalized with UTI and CAP in 49 Michigan hospitals and feedback from end-users, a technical expert panel (TEP), and a patient focus group. Each measure was assessed for reliability, validity, feasibility, and usability. Two measures, now endorsed by the National Quality Forum (NQF), were developed. Measure reliability (derived from 24 483 patients) was excellent (0.90 for UTI; 0.91 for CAP). Both measures had strong validity demonstrated through (a) face validity by hospital users, the TEPs, and patient focus group, (b) implicit case review (ĸ 0.72 for UTI; ĸ 0.72 for CAP), and (c) rare case misclassification (4% for UTI; 0% for CAP) due to data errors (P < .001), supporting usability. We developed highly reliable, valid, and usable measures of inappropriate diagnosis of UTI and CAP for hospitalized patients. Hospitals seeking to improve diagnostic safety, antibiotic use, and patient care should consider using these measures to reduce inappropriate diagnosis of CAP and UTI.
- 31 January 2024
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 78 (6) , 1403-1411
Open AccessDevelopment of Patient Safety Measures to Identify Inappropriate Diagnosis of Common Infections
Inappropriate diagnosis of infections results in antibiotic overuse and may delay diagnosis of underlying conditions. Here we describe the development and characteristics of 2 safety measures of inappropriate diagnosis of urinary tract infection (UTI) and community-acquired pneumonia (CAP), the most common inpatient infections on general medicine services. Measures were developed from guidelines and literature and adapted based on data from patients hospitalized with UTI and CAP in 49 Michigan hospitals and feedback from end-users, a technical expert panel (TEP), and a patient focus group. Each measure was assessed for reliability, validity, feasibility, and usability. Two measures, now endorsed by the National Quality Forum (NQF), were developed. Measure reliability (derived from 24 483 patients) was excellent (0.90 for UTI; 0.91 for CAP). Both measures had strong validity demonstrated through (a) face validity by hospital users, the TEPs, and patient focus group, (b) implicit case review (ĸ 0.72 for UTI; ĸ 0.72 for CAP), and (c) rare case misclassification (4% for UTI; 0% for CAP) due to data errors (P < .001), supporting usability. We developed highly reliable, valid, and usable measures of inappropriate diagnosis of UTI and CAP for hospitalized patients. Hospitals seeking to improve diagnostic safety, antibiotic use, and patient care should consider using these measures to reduce inappropriate diagnosis of CAP and UTI.
- 19 January 2024
- Published by BMJ in BMJ Quality & Safety
- Vol. 33 (2) , 136-140
Quality and safety in the literature: February 2024
- 19 January 2024
- Published by BMJ in BMJ Quality & Safety
- Vol. 33 (2) , 136-140
Quality and safety in the literature: February 2024